1,217
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience

, , , , , , , , ORCID Icon & show all
Article: 2099171 | Received 30 Mar 2022, Accepted 05 Jul 2022, Published online: 21 Jul 2022

References

  • Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, et al. Protecting people with multiple sclerosis through vaccination. Pract Neurol. 2020;1–4. doi:10.1136/practneurol-2020-002527.
  • Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying therapies on responses to vaccinations: a review. Mult Scler Relat Disord. 2020 Oct;45:102439. doi:10.1016/j.msard.2020.102439. Epub 2020 Aug 1.
  • Riva A, Barcella V, Benatti SV, Capobianco M, Capra R, Cinque P, Comi G, Fasolo MM, Franzetti F, Galli M, et al. Vaccinations in patients with multiple sclerosis: a Delphi consensus statement. Mult Scler. 2021 Mar;27(3):347–359. doi:10.1177/1352458520952310. Epub 2020 Sep 17.
  • Yap SM, Al Hinai M, Gaughan M, Callanan I, Kearney H, Tubridy N, McGuigan C. Vaccine hesitancy among people with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov; 56:103236. doi:10.1016/j.msard.2021.103236. Epub 2021 Sep 2.
  • National Plan for Vaccine Prevention 2017-2019; http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
  • Rubin LG, Levin MJ, Per Ljungman E, Graham D, Robin A, Marcie T, Athos B, Shireesha D, Lillian S, Keyserling H, et al. Infectious diseases society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb;58(3):309–318. doi:10.1093/cid/cit816.
  • Dey A, Wang H, Quinn H, Pillsbury A, Glover C, Hickie M, Wood N, Beard F, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2019. Commun Dis Intell (2018). 2021 Apr 30;45. doi:10.33321/cdi.2021.45.23.
  • Farez MF, Correale J, Armstrong MJ, Rae-Grant A, Gloss D, Donley D, Holler-Managan Y, Kachuck NJ, Jeffery D, Beilman M, et al. Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2019 Sep;93(13):584–594. doi:10.1212/WNL.0000000000008157.
  • Sticchi L, Astengo M, Iavarone IG, Icardi G. Utility of serological screening for measles, mumps and rubella in immunocompromised patients. Hum Vaccin Immunother. 2019;15(12):2854–2855. Published online 2019 Sep 17. doi:10.1080/21645515.2019.1657353.
  • Sirbu CA, Florea AA, Ghinescu MC, Docu-Axelerad A, Sirbu AM, Bratu OG, Radu FI. Vaccination in multiple sclerosis - challenging practices (Review). Exp Ther Med. 2020 Dec;20(6):217. doi:10.3892/etm.2020.9347. Epub 2020 Oct 15.
  • Mehling M, Hilbert P, Fritz S, Durovic B, Eichin D, Gasser O, Kuhle J, Klimkait T, Lindberg RLP, Kappos L, et al. Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Ann Neurol. 2011 Feb;69(2):408–413. doi:10.1002/ana.22352.